SG71489G - Parenteral dezocine compositions - Google Patents

Parenteral dezocine compositions

Info

Publication number
SG71489G
SG71489G SG714/89A SG71489A SG71489G SG 71489 G SG71489 G SG 71489G SG 714/89 A SG714/89 A SG 714/89A SG 71489 A SG71489 A SG 71489A SG 71489 G SG71489 G SG 71489G
Authority
SG
Singapore
Prior art keywords
dezocine
vol
percent
parenteral
compositions
Prior art date
Application number
SG714/89A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of SG71489G publication Critical patent/SG71489G/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B61—RAILWAYS
    • B61K—AUXILIARY EQUIPMENT SPECIALLY ADAPTED FOR RAILWAYS, NOT OTHERWISE PROVIDED FOR
    • B61K9/00—Railway vehicle profile gauges; Detecting or indicating overheating of components; Apparatus on locomotives or cars to indicate bad track sections; General design of track recording vehicles
    • B61K9/08—Measuring installations for surveying permanent way
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Laminated Bodies (AREA)
  • Saccharide Compounds (AREA)
SG714/89A 1984-09-28 1989-10-25 Parenteral dezocine compositions SG71489G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65597684A 1984-09-28 1984-09-28

Publications (1)

Publication Number Publication Date
SG71489G true SG71489G (en) 1990-03-02

Family

ID=24631145

Family Applications (1)

Application Number Title Priority Date Filing Date
SG714/89A SG71489G (en) 1984-09-28 1989-10-25 Parenteral dezocine compositions

Country Status (20)

Country Link
US (1) US4605671A (fr)
EP (1) EP0180303B1 (fr)
JP (1) JPH0621060B2 (fr)
KR (1) KR890000905B1 (fr)
AT (1) ATE41602T1 (fr)
AU (1) AU572689B2 (fr)
CA (1) CA1251402A (fr)
CY (1) CY1511A (fr)
DE (1) DE3568942D1 (fr)
DK (1) DK165439C (fr)
GB (1) GB2165149B (fr)
HK (1) HK19990A (fr)
HU (1) HU197667B (fr)
IE (1) IE58139B1 (fr)
IL (1) IL76393A (fr)
MY (1) MY102521A (fr)
NZ (1) NZ213573A (fr)
PH (1) PH20498A (fr)
SG (1) SG71489G (fr)
ZA (1) ZA856680B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
IT1302682B1 (it) 1998-10-16 2000-09-29 Formenti Farmaceutici Spa Composizioni farmaceutiche orali contenenti buprenorfina
CN104523584B (zh) * 2014-12-22 2018-03-30 扬子江药业集团有限公司 一种地佐辛的注射剂及其制备方法
CN106880586A (zh) * 2015-12-16 2017-06-23 天津泰普药品科技发展有限公司 一种稳定的地佐辛注射剂的制备方法
CN110483315B (zh) * 2018-05-15 2021-11-09 扬子江药业集团有限公司 一种地佐辛杂质c的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150147A (en) * 1978-03-24 1979-04-17 American Home Products Corporation Stimulation of prolactin release by an aminotetralin analgesic

Also Published As

Publication number Publication date
MY102521A (en) 1992-07-31
DK438785A (da) 1986-03-29
CA1251402A (fr) 1989-03-21
IL76393A (en) 1988-06-30
EP0180303A1 (fr) 1986-05-07
KR890000905B1 (ko) 1989-04-13
IL76393A0 (en) 1986-01-31
US4605671A (en) 1986-08-12
GB2165149A (en) 1986-04-09
KR860002269A (ko) 1986-04-24
NZ213573A (en) 1988-07-28
GB8521303D0 (en) 1985-10-02
GB2165149B (en) 1988-05-25
EP0180303B1 (fr) 1989-03-22
ATE41602T1 (de) 1989-04-15
PH20498A (en) 1987-01-21
IE852117L (en) 1986-03-28
DK165439B (da) 1992-11-30
AU572689B2 (en) 1988-05-12
DK438785D0 (da) 1985-09-27
AU4713685A (en) 1986-04-10
DE3568942D1 (en) 1989-04-27
JPH0621060B2 (ja) 1994-03-23
ZA856680B (en) 1987-04-29
HUT39359A (en) 1986-09-29
HU197667B (en) 1989-05-29
CY1511A (en) 1990-08-03
HK19990A (en) 1990-03-23
IE58139B1 (en) 1993-07-14
JPS6185314A (ja) 1986-04-30
DK165439C (da) 1993-04-19

Similar Documents

Publication Publication Date Title
HUT44438A (en) Composition comprising l-dopa
ES8702141A1 (es) Procedimiento para preparar una dispersion solida de una dishidropiridina farmacologicamente activa en una matriz cristalina como vehiculo.
DE3568942D1 (en) Parenteral composition
EP0253143A3 (en) Pharmaceutical compositions for suppository
AU578065B2 (en) Stabilized enzyme conjugate compositions
IE882836L (en) Antiviral preparations
EP0303251A3 (en) Modified tpa-containing injection composition
GR3007793T3 (fr)
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
PH24913A (en) Permeation enhancement composition
DE3361270D1 (en) Amine oxide formulations
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
AU557034B2 (en) 3,5-diphenyl-1h-1,2,4-trazoles with contragestational
DE3262234D1 (en) Pharmaceutical compositions with antalgic effect